Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 14, 2017; 23(34): 6261-6272
Published online Sep 14, 2017. doi: 10.3748/wjg.v23.i34.6261
Figure 1
Figure 1 Kaplan-Meier curves of overall survival and disease-free survival of colorectal cancer patients based on neutrophil-lymphocyte ratio (A and D), platelet-lymphocyte ratio (B and E), and systemic immune-inflammation index (C and F).
Figure 2
Figure 2 Receiver operating curve analysis of overall survival (A) and disease-free survival (B). NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio; SII: Systemic immune-inflammation index.
Figure 3
Figure 3 Kaplan-Meier curves of overall survival and disease-free survival of colorectal cancer patients based on different levels of systemic immune-inflammation index. A-D: OS for cases with stages I, II, III, and IV CRC, respectively; E and F: DFS for cases with stages I, II, III, and IV CRC, respectively. OS: Overall survival; DFS: Disease-free survival; CRC: Colorectal cancer.
Figure 4
Figure 4 Kaplan-Meier curves of overall survival and disease-free survival of colorectal cancer patients based on different levels of neutrophil-lymphocyte ratio. A-D: OS for cases with stages I, II, III, and IV CRC, respectively; E and F: DFS for cases with stages I, II, III, and IV CRC, respectively. OS: Overall survival; DFS: Disease-free survival; CRC: Colorectal cancer; NLR: Neutrophil-lymphocyte ratio.
Figure 5
Figure 5 Kaplan-Meier curves of overall survival and disease-free survival of colorectal cancer patients based on different levels of platelet-lymphocyte ratio. A-D: OS for cases with stages I, II, III, and IV CRC, respectively; E-F: DFS for cases with stages I, II, III, and IV CRC, respectively. OS: Overall survival; DFS: Disease-free survival; CRC: Colorectal cancer; PLR: Platelet-lymphocyte ratio.